Al Abbas, A. I., Zenati, M., Reiser, C. J., Hamad, A., Jung, J. P., Zureikat, A. H., . . . Hogg, M. E. (2020). Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. Ann Surg Oncol.

Al Abbas, Amr I., Mazen Zenati, Caroline J. Reiser, Ahmad Hamad, Jae Pil Jung, Amer H. Zureikat, Herbert J. Zeh, và Melissa E. Hogg. "Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma." Ann Surg Oncol 2020.

Al Abbas, Amr I., et al. "Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma." Ann Surg Oncol 2020.